Related Experiment Videos
Infected physicians and invasive procedures: safe practice management
Angelique M Reitsma1, Michael L Closen, Marshall Cunningham
1The Center for Biomedical Ethics, University of Virginia Health Science Center, Charlottesville, VA 22908-0758, USA. ar6j@virginia.edu
Summary
Physicians infected with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) require clear policy guidelines for performing invasive procedures. This study proposes recommendations for managing infected physicians and outlines conditions for practice.
Area of Science:
- Medical Ethics
- Public Health Policy
- Infectious Diseases
Background:
- Lack of current public policy guidance for healthcare professionals with HBV, HCV, and HIV performing invasive procedures.
- Need for evidence-based recommendations to ensure patient safety and physician rights.
- Ethical considerations surrounding serostatus disclosure and professional practice.
Purpose of the Study:
- To develop policy recommendations for physicians infected with HBV, HCV, and/or HIV.
- To establish guidelines for managing infected physicians engaged in invasive procedures.
- To define conditions under which infected physicians can continue practice.
Main Methods:
- Convening a multidisciplinary expert committee including medicine, law, and bioethics specialists.
- Conducting an extensive literature review across infectious diseases, medicine, surgery, epidemiology, law, and bioethics.
- Developing a policy proposal with a list of exposure-prone procedures and a decision chart.
Main Results:
- Identification of key data from literature review to inform policy.
- Formulation of specific recommendations for managing physicians with HIV, HBV, and/or HCV.
- Creation of a decision-making framework for practice continuation based on procedure risk and serostatus.
Conclusions:
- The proposed policy provides a framework for managing infected physicians.
- Recommendations aim to balance patient safety with the professional rights of infected physicians.
- The policy addresses the need for clear guidelines on practice limitations and disclosure for physicians with HBV, HCV, and HIV.